ArticleCancers2022

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.

Ramya Ambur Sankaranarayanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.